Citation tools
"Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-κB Inhibition." Journal of Pharmacology and Experimental Therapeutics
362.1
(2017):
67-77.
Web. 16 April. 2024.